The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Written By LSX
12 September 2018
In this video, Donald Leggatt, Head of Investor Relations at London South E...
Andrew J. Holman, Co-Founder and Chief Executive Officer at Inmedix, talks ...
Fiona Nielsen, Founder and Chief Executive Officer at Repositive, explains ...
Stéphane Boissel, Chief Executive Officer at TxCell, talks to PharmaVenture...
Dieter Willbold, Founder and Chairman of the Supervisory Board at Priavoid,...
Elaine Warburton OBE, Chief Executive Officer at QuantuMDx, discusses the c...
The LSX Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
LSX is an influential community of senior life science decision makers.
We connect senior biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
LSX Nordic Congress: Virtual
Healthtech Leaders: Virtual
LSX USA CEO Forums: Virtual
Inv€$tival Showcase: Virtual
LSX World Congress Virtual